Amlodipine/benazepril
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Amlodipine/benazepril
|
|
| Combination of | |
| Amlodipine | Calcium channel blocker |
| Benazepril | ACE inhibitor |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Therapeutic considerations | |
| Pregnancy cat. |
C (first trimester), D (second trimester) (US) |
| Legal status | |
| Routes | Oral |
Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besylate) with an angiotensin converting enzyme inhibitor (benazepril). This combination agent, and other analogs, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.
[edit] External links
- http://www.lotrel.com
- http://www.drugs.com/lotrel.html
- http://www.rxlist.com/cgi/generic3/amlobenaz.htm
 |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
